Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical ...
Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio
Globus will buy all outstanding Nevro shares for $5.85 per share under the terms of the agreement, therefore reflecting a 27% ...
Globus Medical To Acquire Nevro For $250 Mln
Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, ...
Morningstar6d
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
and other customary closing conditions. Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 ...
Nasdaq6d
Globus Medical to Acquire Nevro Corp. in All-Cash Transaction Valued at $250 Million
and other customary closing conditions. Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 ...
manilatimes6d
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
The transaction is expected to close late in the second quarter of 2025, subject to the approval of Nevro's shareholders, regulatory approval, and other customary closing conditions. Globus Medical ...
ETF Daily News6d
Globus Medical, Inc. (NYSE:GMED) Receives Consensus Rating of “Moderate Buy” from Brokerages
Globus Medical has a 12 month low of $49.33 and ... and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for ...
Nasdaq6d
Globus Medical To Acquire Nevro For $250 Mln
(RTTNews) - Globus Medical (GMED), a musculoskeletal solutions ... and other customary closing conditions. The views and opinions expressed herein are the views and opinions of the author and ...